BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response

Major problems of current antidepressant pharmacotherapy are insufficient response rates and difficulties in response prediction. We recently provided preliminary evidence in a small study that patients with major depressive disorder (MDD) with a hypomethylation of the CpG-87 site of the promoter IV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Psychiatry
Main Authors: Lieb, Klaus, Dreimüller, Nadine, Wagner, Stefanie, Schlicht, Konrad, Falter, Tanja, Neyazi, Alexandra, Müller-Engling, Linda, Bleich, Stefan, Tadić, André, Frieling, Helge
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Psychiatry
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232909/
https://ncbi.nlm.nih.gov/pubmed/30459647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2018.00511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados